You are invited to a Zoom webinar!
When: Apr 18, 2025 01:30 PM Eastern Time (US and Canada)
Topic: SPRING 2025 HUCOP - OFFICE of CPE Clinical & Regulatory Rounds "FREE" CE Webinar Series
"Comparing Phenobarbital and Benzodiazepines for the Management of Acute Alcohol Withdrawal Syndrome (AWS)"
Speaker_Dr. Brittany Leek, HUH PGY1 - Pharmacy Resident
Join from PC, Mac, iPad, or Android:
https://howard.zoom.us/j/83194308582
Phone one-tap:
+13017158592,,83194308582# US (Washington DC)
+13052241968,,83194308582# US
Join via audio:
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 669 444 9171 US
+1 669 900 6833 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
Webinar ID: 831 9430 8582
International numbers available: https://howard.zoom.us/u/kqroO0IrM
Join from an H.323/SIP room system:
H.323:
144.195.19.161 (US West)
206.247.11.121 (US East)
115.114.131.7 (India Mumbai)
115.114.115.7 (India Hyderabad)
159.124.15.191 (Amsterdam Netherlands)
159.124.47.249 (Germany)
159.124.104.213 (Australia Sydney)
159.124.74.212 (Australia Melbourne)
170.114.180.219 (Singapore)
64.211.144.160 (Brazil)
159.124.132.243 (Mexico)
159.124.168.213 (Canada Toronto)
159.124.196.25 (Canada Vancouver)
170.114.194.163 (Japan Tokyo)
147.124.100.25 (Japan Osaka)
Meeting ID: 831 9430 8582
SIP: 83194308582@zoomcrc.com
Date: Apr 18, 2025 01:30 PM - 02:30 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Apr 25, 2025 10:00 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Fellows
- Faculty
- Pharmacy Students
- Residents
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
Howard University Hospital Pharmacy Department is a supporter of this event.
Objectives
- Compare the pharmacokinetic features of benzodiazepines and phenobarbital.
- Identify the various dosing strategies for phenobarbital or the benzodiazepine of choice for the treatment of acute alcohol withdrawal syndrome.
- Evaluate the place in therapy for phenobarbital versus benzodiazepine based current evidence for the management of acute alcohol withdrawal syndrome.
- Given a patient case, determine the most appropriate agent(s) for the treatment of acute alcohol withdrawal syndrome based on patient related factors.
Speaker(s)/Author(s)
|
Dr. Brittany Leek, PharmD |
Activity Number
0010-0000-25-028-L01-P
Date:
04/18/25
Time:
01:30 PM - 02:30 PM
CE Hours
1.00